Literature DB >> 3072086

A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor.

G D Sides1, T R Franson, K A DeSante, H R Black.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3072086

Source DB:  PubMed          Journal:  Clin Ther        ISSN： 0149-2918            Impact factor:   3.393


× No keyword cloud information.
  4 in total

1.  Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.

Authors:  A Iravani
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

2.  Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.

Authors:  N C James; K H Donn; J J Collins; I M Davis; T L Lloyd; R W Hart; J R Powell
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

3.  Mass balance approaches for estimating the intestinal absorption and metabolism of peptides and analogues: theoretical development and applications.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

4.  Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice.

Authors:  J Gisby; B J Wightman; A S Beale
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.